The aim of this study is to assess the fitted parameters of ESWAN in ovarian tumors and to investigate their potential in distinguishing borderline from malignant epithelial ovarian tumors, which can provide detailed information for clinical treatment. R2* and T2* in ESWAN were the key parameters for distinguishing borderline from malignant epithelial ovarian tumors. MR-ESWAN sequence can be used as non-enhancement quantitative indexes, which has a good application prospect.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords